Abstract P1-01-02: Circulating Tumor Cells (CTC) and Endothelial Cells (CEC) Prognostic Value in HER2 Negative Metastatic Breast Cancer Patients Treated with First Line Weekly Paclitaxel and Bevacizumab: First Results of a Prospective Cohort from the French Breast Cancer InterGroup Unicancer (UCBG): COMET Study
Cancer Research(2017)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要